Synopsys vs Workday
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put Synopsys and Workday side by side, using each one’s latest annual report. Here is what stands out:
- Workday is the larger business, with $9.6B of revenue in fiscal 2026 against $7.1B for Synopsys.
- Synopsys grew revenue faster (15.1%, against 13.1%).
- Synopsys kept more of each dollar of sales as operating profit (13.0% operating margin, against 7.6%).
- Workday turned more of its sales into free cash flow (29.1% FCF margin, against 19.1%).
- Workday earned a higher return on the capital invested in it (10.6%, against 4.0%).
- Investors pay more for each dollar of Synopsys’s earnings: a P/E of 79.4x against 42.2x for Workday.
Who comes out ahead
Of the 10 measures where higher (or lower) is clearly better, how many each company leads.
Synopsys
SNPS
3/10
Revenue growthOperating marginNet margin
Workday
WDAY
7/10
5-year growthFCF marginReturn on capitalReturn on equityPiotroski F-scoreNet debt / EBITDAShare count change
Side by side
Best in the row
| Latest fiscal year | SNPS FY25 | WDAY FY26 |
|---|---|---|
| Size | ||
| Market cap | $87.4B | $51.4B |
| Revenue | $7.1B | $9.6B |
| Free cash flow | $1.3B | $2.8B |
| Net income | $1.3B | $693M |
| Growth | ||
| Revenue growth | 15.1% | 13.1% |
| 5-year growth | 13.9% | 17.2% |
| Share count change | 6.2% | −0.4% |
| Profitability | ||
| Gross margin | 77.0% | — |
| Operating margin | 13.0% | 7.6% |
| Net margin | 18.9% | 7.3% |
| FCF margin | 19.1% | 29.1% |
| Return on capital | 4.0% | 10.6% |
| Return on equity | 7.1% | 8.2% |
| Balance sheet | ||
| Net debt | $10.5B | −$2.5B |
| Net debt / EBITDA | 6.7x | −2.6x |
| Dividends and buybacks | $0.0M | $2.9B |
| Valuation & quality | ||
| P/E | 79.4x | 42.2x |
| Piotroski F-score | 3 | 7 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.